Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - New York Stock Exchange, Inc. - US10948C1071 - Common Stock - Currency: USD

13.43  -0.26 (-1.9%)

After market: 13.53 +0.1 (+0.74%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BV. BV was compared to 84 industry peers in the Commercial Services & Supplies industry. The financial health of BV is average, but there are quite some concerns on its profitability. BV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BV was profitable.
BV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BV reported negative net income in multiple years.
BV had a positive operating cash flow in each of the past 5 years.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV has a Return On Assets of 0.77%. This is comparable to the rest of the industry: BV outperforms 46.34% of its industry peers.
BV has a Return On Equity (1.43%) which is in line with its industry peers.
BV has a Return On Invested Capital of 2.85%. This is comparable to the rest of the industry: BV outperforms 40.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BV is significantly below the industry average of 10.12%.
The 3 year average ROIC (2.40%) for BV is below the current ROIC(2.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.77%
ROE 1.43%
ROIC 2.85%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

The Profit Margin of BV (0.93%) is comparable to the rest of the industry.
BV's Profit Margin has declined in the last couple of years.
BV has a Operating Margin (4.34%) which is comparable to the rest of the industry.
BV's Operating Margin has declined in the last couple of years.
The Gross Margin of BV (23.31%) is worse than 67.07% of its industry peers.
In the last couple of years the Gross Margin of BV has declined.
Industry RankSector Rank
OM 4.34%
PM (TTM) 0.93%
GM 23.31%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

BV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BV has less shares outstanding
Compared to 1 year ago, BV has an improved debt to assets ratio.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.50, we must say that BV is in the distress zone and has some risk of bankruptcy.
BV's Altman-Z score of 1.50 is on the low side compared to the rest of the industry. BV is outperformed by 63.41% of its industry peers.
The Debt to FCF ratio of BV is 7.05, which is on the high side as it means it would take BV, 7.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.05, BV is in the better half of the industry, outperforming 60.98% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that BV is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.45, BV perfoms like the industry average, outperforming 53.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 7.05
Altman-Z 1.5
ROIC/WACC0.37
WACC7.75%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BV has a Current Ratio of 1.43. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV has a Current ratio (1.43) which is in line with its industry peers.
BV has a Quick Ratio of 1.43. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV has a better Quick ratio (1.43) than 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.43
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

BV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.76%, which is quite impressive.
Measured over the past years, BV shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.19% on average per year.
The Revenue has decreased by -1.69% in the past year.
Measured over the past years, BV shows a small growth in Revenue. The Revenue has been growing by 2.85% on average per year.
EPS 1Y (TTM)32.76%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%100%
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.39%

3.2 Future

The Earnings Per Share is expected to grow by 13.16% on average over the next years. This is quite good.
BV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.83% yearly.
EPS Next Y15.2%
EPS Next 2Y14.62%
EPS Next 3Y13.16%
EPS Next 5YN/A
Revenue Next Year1.02%
Revenue Next 2Y2.31%
Revenue Next 3Y2.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.44, which indicates a rather expensive current valuation of BV.
70.73% of the companies in the same industry are more expensive than BV, based on the Price/Earnings ratio.
BV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.63.
The Price/Forward Earnings ratio is 13.63, which indicates a correct valuation of BV.
81.71% of the companies in the same industry are more expensive than BV, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, BV is valued a bit cheaper.
Industry RankSector Rank
PE 17.44
Fwd PE 13.63
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BV is valued a bit cheaper than 79.27% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 79.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.36
EV/EBITDA 7.54
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

BV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BV's earnings are expected to grow with 13.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.15
PEG (5Y)N/A
EPS Next 2Y14.62%
EPS Next 3Y13.16%

0

5. Dividend

5.1 Amount

No dividends for BV!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (2/21/2025, 8:04:40 PM)

After market: 13.53 +0.1 (+0.74%)

13.43

-0.26 (-1.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners69.34%
Inst Owner Change-1.52%
Ins Owners2.71%
Ins Owner Change0.91%
Market Cap1.28B
Analysts81.11
Price Target18.92 (40.88%)
Short Float %7.31%
Short Ratio8.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP105.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.32%
Min EPS beat(2)-4.54%
Max EPS beat(2)1.9%
EPS beat(4)2
Avg EPS beat(4)11.75%
Min EPS beat(4)-4.54%
Max EPS beat(4)51.33%
EPS beat(8)4
Avg EPS beat(8)0.15%
EPS beat(12)6
Avg EPS beat(12)6.63%
EPS beat(16)7
Avg EPS beat(16)10.44%
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-4.84%
Max Revenue beat(2)-2.17%
Revenue beat(4)0
Avg Revenue beat(4)-3.52%
Min Revenue beat(4)-4.84%
Max Revenue beat(4)-2.17%
Revenue beat(8)0
Avg Revenue beat(8)-3.48%
Revenue beat(12)2
Avg Revenue beat(12)-2%
Revenue beat(16)4
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)8.81%
EPS NQ rev (1m)-0.83%
EPS NQ rev (3m)-2.32%
EPS NY rev (1m)-1.45%
EPS NY rev (3m)-3.05%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 17.44
Fwd PE 13.63
P/S 0.47
P/FCF 11.36
P/OCF 5.35
P/B 0.72
P/tB N/A
EV/EBITDA 7.54
EPS(TTM)0.77
EY5.73%
EPS(NY)0.99
Fwd EY7.34%
FCF(TTM)1.18
FCFY8.8%
OCF(TTM)2.51
OCFY18.7%
SpS28.69
BVpS18.56
TBVpS-3.46
PEG (NY)1.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.43%
ROCE 4.2%
ROIC 2.85%
ROICexc 2.95%
ROICexgc 12.86%
OM 4.34%
PM (TTM) 0.93%
GM 23.31%
FCFM 4.12%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score6
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 7.05
Debt/EBITDA 3
Cap/Depr 86.39%
Cap/Sales 4.64%
Interest Coverage 1.83
Cash Conversion 90.22%
Profit Quality 444.49%
Current Ratio 1.43
Quick Ratio 1.43
Altman-Z 1.5
F-Score6
WACC7.75%
ROIC/WACC0.37
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.76%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%100%
EPS Next Y15.2%
EPS Next 2Y14.62%
EPS Next 3Y13.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.39%
Revenue Next Year1.02%
Revenue Next 2Y2.31%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y22.83%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year74.28%
EBIT Next 3Y25.87%
EBIT Next 5YN/A
FCF growth 1Y1920.97%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y140.62%
OCF growth 3Y11.48%
OCF growth 5Y3.91%